Loading...
XNAS
RDNT
Market cap6.06bUSD
Dec 05, Last price  
78.59USD
1D
-3.07%
1Q
10.05%
Jan 2017
1,118.45%
IPO
2,706.79%
Name

RadNet Inc

Chart & Performance

D1W1MN
XNAS:RDNT chart
P/E
2,170.76
P/S
3.31
EPS
0.04
Div Yield, %
—
Shrs. gr., 5y
8.27%
Rev. gr., 5y
9.65%
Revenues
1.83b
+13.18%
145,573,000161,005,000425,470,000502,118,000524,368,000548,537,000619,800,000647,153,000702,986,000717,569,000809,628,000884,535,000922,186,000975,146,0001,154,179,0001,071,840,0001,315,077,0001,430,061,0001,616,630,0001,829,664,000
Net income
3m
-8.25%
-3,135,000-6,894,000-18,131,000-12,836,000-2,267,000-12,852,0007,231,00064,517,0002,120,0001,376,0007,709,0007,230,00053,00032,243,00023,440,000-1,749,00044,319,00033,608,0003,044,0002,793,000
CFO
233m
+5.51%
22,002,00010,251,00029,201,00045,201,00076,618,00066,884,00057,636,00074,033,00066,422,00061,004,00067,037,00091,599,000141,187,000116,754,000104,322,000233,759,000149,491,000146,417,000220,863,000233,023,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems for the diagnostic imaging industry, including picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of images in the field of mammography, as well as AI solutions for lung and prostate cancer. As of December 31, 2021, it owned and managed 347 centers in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. The company was founded in 1981 and is headquartered in Los Angeles, California.
URL
https://www.radnet.com/
IPO date
Dec 12, 2001
Employees
9,000
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT